Terumo inks deal for Arterial Remodeling's bioresorbable stent

Terumo inks a structured deal for Arterial Remodeling Technologies' bioresorbable drug-eluting coronary stent.

Arterial Remodeling Technologies said it inked a deal with Terumo Corp. (TYO:4543) for its bioresorbable drug-eluting coronary stent that includes an exclusive buyout option.

Arterial Remodeling Technologies, Terumo Corp.

News Well, Bioabsorbable Stents, Drug-Eluting Stents, Mergers & Acquisitions, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1gFU3CJ